Friday, July 29, 2011
Friday, May 27, 2011
Sunday, March 13, 2011
Friday, March 11, 2011
Tuesday, November 2, 2010
Thursday, October 7, 2010
Friday, June 11, 2010
Wednesday, June 9, 2010
Monday, June 7, 2010
Thursday, June 3, 2010
Saturday, May 29, 2010
Monday, May 24, 2010
Saturday, May 22, 2010
Friday, May 21, 2010
Wednesday, May 19, 2010
Monday, May 17, 2010
Sunday, May 16, 2010
Friday, May 14, 2010
Thursday, May 13, 2010
Wednesday, May 12, 2010
Monday, May 10, 2010
Sunday, May 9, 2010
Saturday, May 8, 2010
Tuesday, May 4, 2010
Monday, May 3, 2010
Saturday, May 1, 2010
MRSA Infection: Notes of Important Points
Community-Acquired MRSA
The recent rapid increase in community-acquired MRSA soft tissue infections has forced physicians to reconsider their approach to routine SSTIs. Recent reports of antimicrobial resistance patterns have found that community-acquired MRSA is responsible for up to 60 percent of SSTIs in U.S. emergency departments.10,11 These rates are higher in certain populations, including ethnic minorities, children, intravenous drug users, patients who have received recent antibiotic treatment, men who have sex with men, residents of long-term care facilities and prisons, and patients receiving hemodialysis.5,12,13 In addition to purulent SSTIs, community-acquired MRSA is associated with other infectious processes, such as necrotizing pneumonia and sepsis.10 Although many patients with community-acquired MRSA infections describe the initial presentation as resembling a spider bite, there are no reliable signs and symptoms to distinguish community-acquired MRSA infections from other purulent SSTIs.13,14
Diagnosis and Assessment of SSTIs
SSTIs in the presence of comorbid infections, such as
diabetes,
neutropenia,
or cirrhosis, are more likely to be severe and caused by uncommon organisms (e.g., Pseudomonas species, Klebsiella species, yeast, fungi).7
Complicated and potentially life-threatening SSTIs are characterized by fever,
widespread or a rapidly spreading area of involvement, firm and hard feel of subcutaneous tissues, pain disproportionate to examination, skin sloughing, cutaneous bleeding with or without bullae, and skin crepitus.15 Additionally, patients with necrotizing infections may be lethargic or disorientated.7 Rapidly progressive and life-threatening infections warrant urgent surgical referral.3,7,16
Hospitalization should be considered in patients with the following laboratory findings:
left shift in complete blood count with differential,
elevated serum creatinine level,
reduced serum bicarbonate level,
elevated creatine kinase level, or
C-reactive protein level greater than 13 mg per L (123.81 nmol per L).7
wound cultures of purulent secretions should be performed in patients with multiple or extensive lesions,
fever or other evidence of systemic illness,
prior treatment failure, immunocompromise, trauma, water contact, or animal or human bites.7 If wound cultures are indicated, fluid or tissue specimens should be collected using aseptic technique via needle aspiration or tissue biopsy.
Antimicrobial Treatment
When indicated, antimicrobial therapy for uncomplicated SSTIs is usually initiated empirically. Familiarity with common pathogens and with local flora and resistance patterns is essential in choosing initial agents.
Oral antibiotics that have been shown to be effective against community-acquired MRSA include
trimethoprim/sulfamethoxazole (Bactrim, Septra),
tetracyclines, and
Local patterns of sensitivity may vary, however. In one study, patients with uncomplicated cellulitis who received five days of antibiotic treatment had similar outcomes to those who were treated for 10 days.26 In patients with widespread or systemic infection, comorbidities, or an inability to tolerate oral treatment, vancomycin is the first-line parenteral anti-MRSA agent, although clindamycin, quinolones, linezolid (Zyvox), tigecycline (Tygacil), and daptomycin (Cubicin) may also be used.3
If clindamycin therapy is considered,
a D-zone test should be performed to
identify patients with inducible clindamycin resistance.
LINEZOLID
Linezolid is effective against methicillin-sensitive S. aureus (MSSA) and MRSA, and the nearly equal bioavailability of oral and intravenous preparations makes it a convenient alternative to vancomycin. Because of cost (approximately $1,700 for a 10-day oral course) and the potential for the development of additional drug resistance, linezolid should be reserved for patients with MRSA who do not respond to other agents and for patients with complicated SSTIs in whom alternative treatment has been inferior.
1.As a weak monoamine oxidase inhibitor, linezolid may be associated with an increase in blood pressure.
2. Serotonin syndrome has been reported in patients taking selective serotonin reuptake inhibitors with line-zolid.
3.Linezolid also should be used with caution in patients with chronic kidney disease because it is renally excreted.26
TIGECYCLINE
Tigecycline is indicated for the treatment of complicated SSTIs caused by MSSA and MRSA infections.
The drug is metabolized in the liver; therefore, dosing adjustments are
needed in patients with severely impaired liver function (i.e., those with Child-Pugh classification C cirrhosis).
No dosing adjustment is needed in patients with renal impairment,
and tigecycline does not alter the effectiveness of warfarin (Coumadin) therapy.31
Tigecycline is administered intravenously.
The most common adverse effects are nausea and vomiting.
As with tetracyclines,
tigecycline is not recommended
for use in children.31
DAPTOMYCIN
Daptomycin exhibits bactericidal activity against most gram-positive organisms, including MRSA and vancomycin-resistant enterococci. This unique medication disrupts the ionic electric potentials of the cell membrane by promoting rapid calcium-dependent efflux of potassium from the cell.32,33 In a prospective, open-label study comparing daptomycin with vancomycin for the treatment of complicated SSTIs with risk of MRSA, both groups had complete clinical resolution, with the daptomycin-treated group demonstrating a significantly reduced duration of intravenous therapy and reduced median number of days to achieve clinical cure.34
Daptomycin is administered intravenously.
Potential adverse effects include myopathy and gastrointestinal effects,
such as nausea, vomiting, and diarrhea.
Daptomycin may elevate the prothrombin time and, therefore,
should be used with caution in patients taking warfarin.33
RETAPAMULIN
Retapamulin (Altabax) is a topical antibiotic that has been investigated for use in the treatment of impetigo.
cally significant improvement in outcomes after seven days of retapamulin therapy, compared with placebo.35 Retapamulin has not been compared with topical mupirocin, however.
Prevention of SSTIs
Standard infection control precautions should be implemented and encouraged for all patients in ambulatory and inpatient settings, including
proper and frequent handwashing,
use of gloves when managing wounds, and
contact precautions (e.g., use of gowns and gloves, grouping patients with similar infections) for patients with known or suspected MRSA infections.12 To prevent SSTIs, current consensus guidelines support proper foot care among patients with diabetes, tinea pedis, or pedal edema from venous insufficiency or lymphedema.
Wednesday, April 28, 2010
Tuesday, April 27, 2010
Saturday, April 24, 2010
Tuesday, April 6, 2010
Thursday, April 1, 2010
Wednesday, March 31, 2010
Monday, March 29, 2010
Friday, March 26, 2010
Tuesday, March 23, 2010
Friday, March 19, 2010
Wednesday, March 17, 2010
Monday, March 8, 2010
Friday, February 19, 2010
Sunday, February 14, 2010
Tuesday, February 2, 2010
Monday, February 1, 2010
Sunday, January 31, 2010
Saturday, January 30, 2010
Thursday, January 28, 2010
Tuesday, January 26, 2010
Necrotizing Fasciitis
Monday, January 25, 2010
Sunday, January 24, 2010
Saturday, January 23, 2010
Friday, January 22, 2010
Thursday, January 21, 2010
Monday, January 18, 2010
Saturday, January 16, 2010
Friday, January 15, 2010
Thursday, January 14, 2010
Wednesday, January 13, 2010
Thursday, January 7, 2010
Wednesday, December 30, 2009
Thursday, December 24, 2009
Tuesday, December 22, 2009
Sunday, December 20, 2009
Friday, December 18, 2009
Wednesday, December 16, 2009
Sunday, December 13, 2009
Friday, December 11, 2009
Wednesday, December 9, 2009
Tuesday, December 8, 2009
Friday, December 4, 2009
Tuesday, November 10, 2009
Saturday, September 26, 2009
Saturday, September 12, 2009
Monday, April 27, 2009
Tuesday, April 14, 2009
Monday, April 13, 2009
Friday, April 10, 2009
Thursday, April 9, 2009
Tuesday, April 7, 2009
Sunday, April 5, 2009
Friday, April 3, 2009
Tuesday, March 31, 2009
Friday, March 27, 2009
Tuesday, March 24, 2009
Monday, March 9, 2009
Thursday, February 12, 2009
Monday, January 26, 2009
Monday, January 19, 2009
Friday, January 16, 2009
Thursday, January 15, 2009
Wednesday, December 17, 2008
Wednesday, December 10, 2008
Monday, December 8, 2008
Friday, December 5, 2008
Wednesday, December 3, 2008
Sunday, October 26, 2008
Wednesday, October 22, 2008
Monday, October 20, 2008
Saturday, October 18, 2008
Thursday, October 16, 2008
Wednesday, October 15, 2008
Wednesday, October 8, 2008
Monday, October 6, 2008
Saturday, October 4, 2008
Thursday, October 2, 2008
Wednesday, October 1, 2008
Monday, September 29, 2008
Friday, September 26, 2008
Thursday, September 25, 2008
Tuesday, September 23, 2008
Sunday, September 21, 2008
Thursday, September 18, 2008
Wednesday, September 17, 2008
Tuesday, September 16, 2008
Sunday, September 14, 2008
Saturday, September 13, 2008
Friday, September 12, 2008
Thursday, September 11, 2008
Wednesday, September 10, 2008
Monday, September 8, 2008
Saturday, September 6, 2008
Thursday, September 4, 2008
Tuesday, September 2, 2008
Sunday, August 31, 2008
Saturday, August 30, 2008
Thursday, August 28, 2008
Wednesday, August 27, 2008
Tuesday, August 26, 2008
Monday, August 25, 2008
Sunday, August 24, 2008
Saturday, August 23, 2008
Thursday, August 21, 2008
Wednesday, August 20, 2008
Changes During Normal Aging
Aging is a process that requires adaptation to the changes associated wtih the increasing age. Care for the elderly involves, among others, the management of most common clinical conditions that affict the aged such as arthritis, hypertension, diabetes mellitus, urinary incontinence, heart disease, hearing loss, influenza, depression, falls and injuries.
Preventive strategies should be targeted at the major causes of death such as coronary heart disease, cancer, and stroke. Replacement therapy with estrogens and progesterone decreases the incidence of osteoporosis. Principal goal of health care to the elderly: Delaying morbidity and disability.
Physical Activity: Older adults should be counseled on physical exercise when there are no contraindications such as decompensated heart failure, severe aortic stenosis, serious cardiac arrhtymias etc.
Brain: atrophy of the brain tissue, senile plaques, neurofibrillary tangles, loss of memory
Respiratory System: Increase in FRC with aging, decrease in pulmonary diffusing capacity, decrease in arterial oxygen tension
Cardiovascular system: decrease in cardiac index, increase in myocardial stiffness, decrease in arterial compliance, increase in total peripheral vascular resistance
Renal System: glomerulosclerosis, impaired sodium handling
Sleep: Wakefulness After Sleep Onset, Increased number of arousals, insomnia
Which of the following is a common process associated with normal aging?
A.increase in cardiac fibrosis
B. increase in cardiac index
C. Decrease in total peripheral vascular resistance
D. Decrease in WASO (Wakefulness After Sleep Onset)
Answer: A

